Tempus AI, Inc. (NASDAQ:TEM) Receives Average Rating of "Moderate Buy" from Brokerages

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the thirteen brokerages that are currently covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $61.08.

A number of analysts have recently issued reports on the stock. JPMorgan Chase & Co. lowered shares of Tempus AI from an "overweight" rating to a "neutral" rating and lifted their price objective for the company from $50.00 to $55.00 in a research note on Tuesday, February 25th. Loop Capital cut their price objective on shares of Tempus AI from $57.00 to $52.00 and set a "buy" rating on the stock in a report on Tuesday, January 14th. Morgan Stanley raised their target price on Tempus AI from $50.00 to $60.00 and gave the company an "overweight" rating in a research note on Thursday, March 6th. William Blair reiterated a "market perform" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Finally, BTIG Research initiated coverage on Tempus AI in a research note on Monday, April 21st. They set a "buy" rating and a $60.00 price objective for the company.

Tempus AI Stock Down 5.3 %

NASDAQ TEM traded down $3.46 during trading hours on Monday, hitting $61.76. The company had a trading volume of 9,602,759 shares, compared to its average volume of 5,990,442. The firm's 50 day moving average is $48.22 and its 200 day moving average is $50.87. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. Tempus AI has a fifty-two week low of $22.89 and a fifty-two week high of $91.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.27) by $0.03. The company had revenue of $255.74 million during the quarter, compared to analyst estimates of $248.13 million. The company's quarterly revenue was up 75.4% compared to the same quarter last year. On average, research analysts anticipate that Tempus AI will post -6.15 EPS for the current fiscal year.

Insider Activity at Tempus AI

In other Tempus AI news, Director Wayne A.I. Frederick sold 3,000 shares of the business's stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $45.54, for a total transaction of $136,620.00. Following the completion of the transaction, the director now directly owns 26,514 shares of the company's stock, valued at $1,207,447.56. The trade was a 10.16 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Andrew Polovin sold 13,135 shares of the firm's stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $45.98, for a total value of $603,947.30. Following the completion of the sale, the executive vice president now owns 154,171 shares in the company, valued at approximately $7,088,782.58. This represents a 7.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 4,237,561 shares of company stock valued at $251,210,331. Corporate insiders own 27.60% of the company's stock.

Institutional Trading of Tempus AI

A number of institutional investors have recently made changes to their positions in TEM. Operose Advisors LLC bought a new stake in Tempus AI during the fourth quarter worth approximately $25,000. Cherry Tree Wealth Management LLC acquired a new position in shares of Tempus AI during the 1st quarter valued at $31,000. University of Texas Texas AM Investment Management Co. bought a new stake in shares of Tempus AI in the 1st quarter worth $33,000. Farther Finance Advisors LLC acquired a new stake in shares of Tempus AI in the fourth quarter valued at $34,000. Finally, Prestige Wealth Management Group LLC boosted its stake in Tempus AI by 910.4% during the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock valued at $36,000 after buying an additional 965 shares in the last quarter. 24.22% of the stock is owned by institutional investors and hedge funds.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.